Works matching AU Lonial, Sagar

Results: 215
    1
    2

    Phase III Studies in Myeloma.

    Published in:
    Clinical Lymphoma & Myeloma, 2009, v. 9, p. S33
    By:
    • Moreau, Philip;
    • Lonial, Sagar;
    • Reece, Donna E.;
    • Boccadoro, Mario;
    • Sonneveld, Pieter
    Publication type:
    Article
    3
    4
    5
    6

    Maintenance Therapy in Lymphoma.

    Published in:
    Clinical Lymphoma & Myeloma, 2007, v. 7, n. 8, p. 507
    By:
    • Mihelic, Ronald;
    • Kaufman, Jonathan;
    • Lonial, Sagar;
    • Flowers, Christopher
    Publication type:
    Article
    7
    8
    9
    10

    Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 66, doi. 10.1111/bjh.14821
    By:
    • San‐Miguel, Jesús F.;
    • Hungria, Vania T. M.;
    • Yoon, Sung‐Soo;
    • Beksac, Meral;
    • Dimopoulos, Meletios A.;
    • Elghandour, Ashraf;
    • Jedrzejczak, Wieslaw W.;
    • Guenther, Andreas;
    • Na Nakorn, Thanyaphong;
    • Siritanaratkul, Noppadol;
    • Schlossman, Robert L.;
    • Hou, Jian;
    • Moreau, Philippe;
    • Lonial, Sagar;
    • Lee, Jae‐Hoon;
    • Einsele, Hermann;
    • Salwender, Hans;
    • Sopala, Monika;
    • Redhu, Suman;
    • Paul, Sofia
    Publication type:
    Article
    11

    Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 6, p. 896, doi. 10.1111/bjh.14787
    By:
    • Dimopoulos, Meletios A.;
    • Lonial, Sagar;
    • White, Darrell;
    • Moreau, Philippe;
    • Palumbo, Antonio;
    • San‐Miguel, Jesus;
    • Shpilberg, Ofer;
    • Anderson, Kenneth;
    • Grosicki, Sebastian;
    • Spicka, Ivan;
    • Walter‐Croneck, Adam;
    • Magen, Hila;
    • Mateos, Maria‐Victoria;
    • Belch, Andrew;
    • Reece, Donna;
    • Beksac, Meral;
    • Bleickardt, Eric;
    • Poulart, Valerie;
    • Sheng, Jennifer;
    • Sy, Oumar
    Publication type:
    Article
    12

    Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 4, p. 571, doi. 10.1111/bjh.14733
    By:
    • Kumar, Shaji;
    • Moreau, Philippe;
    • Hari, Parameswaran;
    • Mateos, Maria ‐ Victoria;
    • Ludwig, Heinz;
    • Shustik, Chaim;
    • Masszi, Tamas;
    • Spencer, Andrew;
    • Hájek, Roman;
    • Romeril, Kenneth;
    • Avivi, Irit;
    • Liberati, Anna M.;
    • Minnema, Monique C.;
    • Einsele, Hermann;
    • Lonial, Sagar;
    • Berg, Deborah;
    • Lin, Jianchang;
    • Gupta, Neeraj;
    • Esseltine, Dixie ‐ Lee;
    • Richardson, Paul G.
    Publication type:
    Article
    13

    A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.

    Published in:
    British Journal of Haematology, 2015, v. 171, n. 4, p. 539, doi. 10.1111/bjh.13637
    By:
    • Cohen, Jonathon B.;
    • Switchenko, Jeffrey M.;
    • Koff, Jean L.;
    • Sinha, Rajni;
    • Kaufman, Jonathan L.;
    • Khoury, H. Jean;
    • Bumpers, Nassoma;
    • Colbert, Amanda;
    • Hutchison‐Rzepka, Amanda;
    • Nastoupil, Loretta J.;
    • Heffner, Leonard T.;
    • Langston, Amelia A.;
    • Lechowicz, Mary Jo;
    • Lonial, Sagar;
    • Flowers, Christopher R.
    Publication type:
    Article
    14

    Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 5, p. 608, doi. 10.1111/j.1365-2141.2012.09209.x
    By:
    • Muringampurath-John, Disni;
    • Jaye, David L.;
    • Flowers, Christopher R.;
    • Saxe, Debra;
    • Chen, Zhengjia;
    • Lechowicz, Mary J.;
    • Weisenburger, Dennis D.;
    • Bast, Martin;
    • Arellano, Martha L.;
    • Bernal-Mizrachi, Leon;
    • Heffner, Leonard T.;
    • McLemore, Morgan;
    • Kaufman, Jonathan L.;
    • Winton, Elliott F.;
    • Lonial, Sagar;
    • Armitage, James O.;
    • Khoury, Hanna J.
    Publication type:
    Article
    15
    16
    17
    18

    PB2132: EXCALIBER‐RRMM: A PHASE 3, TWO‐STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975292.31324.26
    By:
    • Lonial, Sagar;
    • Quach, Hang;
    • Dimopoulos, Meletios A.;
    • Rodríguez‐Otero, Paula;
    • Berdeja, Jesus;
    • Richardson, Paul;
    • Kyada, Margee;
    • Chu, Shuyu;
    • Chen, Min;
    • Abad, Patricia;
    • Morando, Juliane;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    19

    P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE‐EXPANSION PHASE OF THE CC‐92480‐MM‐001 TRIAL.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970376.71405.63
    By:
    • Bahlis, Nizar J;
    • Trudel, Suzanne;
    • Quach, Hang;
    • Popat, Rakesh;
    • Lonial, Sagar;
    • Orlowski, Robert Z;
    • Kim, Kihyun;
    • Mateos, Maria‐Victoria;
    • Pawlyn, Charlotte;
    • Ramasamy, Karthik;
    • Martinez‐Lopez, Joaquín;
    • Casas‐Avilés, Ignacio;
    • Spirli, Alessia;
    • Gong, Jing;
    • Amatangelo, Michael;
    • Katz, Jessica;
    • Maciag, Paulo;
    • Peluso, Teresa;
    • Richardson, Paul
    Publication type:
    Article
    20

    P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF AZD5991 IN RELAPSED/ REFRACTORY HEMATOLOGIC MALIGNANCIES: A PHASE 1 FIRST‐IN‐HUMAN STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969220.98838.e7
    By:
    • Desai, Pinkal;
    • Lonial, Sagar;
    • Cashen, Amanda;
    • Kamdar, Manali;
    • Blachly, James S.;
    • Flinn, Ian W.;
    • O’brien, Susan;
    • Garcia, Jacqueline;
    • Korde, Neha;
    • Moslehi, Javid;
    • Wey, Margaret;
    • Cheung, Patricia;
    • Sharma, Shringi;
    • Olabode, Damilola;
    • Chen, Hong;
    • Ali Syed, Firasath;
    • Liu, Mary;
    • Saeh, Jamal;
    • Tibes, Raoul;
    • Andrade, Marcio
    Publication type:
    Article
    21
    22

    Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

    Published in:
    2020
    By:
    • Farooq, Asim V.;
    • Degli Esposti, Simona;
    • Popat, Rakesh;
    • Thulasi, Praneetha;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Jakubowiak, Andrzej;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Gupta, Ira;
    • Colby, Kathryn
    Publication type:
    Correction Notice
    23

    Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

    Published in:
    Ophthalmology & Therapy, 2020, v. 9, n. 4, p. 889, doi. 10.1007/s40123-020-00280-8
    By:
    • Farooq, Asim V.;
    • Degli Esposti, Simona;
    • Popat, Rakesh;
    • Thulasi, Praneetha;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Jakubowiak, Andrzej;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Gupta, Ira;
    • Colby, Kathryn
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells.

    Published in:
    Nucleic Acids Research, 2024, v. 52, n. 13, p. 7539, doi. 10.1093/nar/gkae427
    By:
    • Cinar, Munevver;
    • Martinez-Medina, Lourdes;
    • Puvvula, Pavan K;
    • Arakelyan, Arsen;
    • Vardarajan, Badri N;
    • Anthony, Neil;
    • Nagaraju, Ganji P;
    • Park, Dongkyoo;
    • Feng, Lei;
    • Sheff, Faith;
    • Mosunjac, Marina;
    • Saxe, Debra;
    • Flygare, Steven;
    • Alese, Olatunji B;
    • Kaufman, Jonathan L;
    • Lonial, Sagar;
    • Sarmiento, Juan M;
    • Lossos, Izidore S;
    • Vertino, Paula M;
    • Lopez, Jose A
    Publication type:
    Article
    38
    39

    Gene integrated set profile analysis: a context-based approach for inferring biological endpoints.

    Published in:
    Nucleic Acids Research, 2016, v. 44, n. 7, p. e69, doi. 10.1093/nar/gkv1503
    By:
    • Kowalski, Jeanne;
    • Dwivedi, Bhakti;
    • Newman, Scott;
    • Switchenko, Jeffery M.;
    • Pauly, Rini;
    • Gutman, David A.;
    • Arora, Jyoti;
    • Gandhi, Khanjan;
    • Ainslie, Kylie;
    • Doho, Gregory;
    • Qin, Zhaohui;
    • Moreno, Carlos S.;
    • Rossi, Michael R.;
    • Vertino, Paula M.;
    • Lonial, Sagar;
    • Bernal-Mizrachi, Leon;
    • Boise, Lawrence H.
    Publication type:
    Article
    40
    41
    42

    Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 383, doi. 10.3109/10428194.2014.921296
    By:
    • Nastoupil, Loretta J.;
    • Shenoy, Pareen J.;
    • Ambinder, Alex;
    • Koff, Jean L.;
    • Nooka, Ajay K.;
    • Waller, Edmund K.;
    • Langston, Amelia;
    • Seward, Miray;
    • Kaufman, Jonathan L.;
    • Bernal-Mizrachi, Leon;
    • King, Nassoma;
    • Lechowicz, Mary Jo;
    • Lonial, Sagar;
    • Sinha, Rajni;
    • Flowers, Christopher R.
    Publication type:
    Article
    43
    44

    Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 4, p. 725, doi. 10.3109/10428194.2011.619019
    By:
    • Muringampurath-John, Disni;
    • Flowers, Christopher R.;
    • Toscano, Michael;
    • Zhengjia, Chen;
    • Kaufman, Jonathan L.;
    • Arellano, Martha;
    • Bernal-Mizrachi, Leon;
    • Heffner, Leonard T.;
    • Lechowicz, Mary-Jo;
    • McLemore, Morgan;
    • Winton, Elliott;
    • Jaye, David L.;
    • Lonial, Sagar;
    • Khoury, Hanna Jean
    Publication type:
    Article
    45
    46
    47

    High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.

    Published in:
    Cytometry. Part A, 2019, v. 95, n. 3, p. 279, doi. 10.1002/cyto.a.23693
    By:
    • Adams, Homer C.;
    • Stevenaert, Frederik;
    • Krejcik, Jakub;
    • Van der Borght, Koen;
    • Smets, Tina;
    • Bald, Jaime;
    • Abraham, Yann;
    • Ceulemans, Hugo;
    • Chiu, Christopher;
    • Vanhoof, Greet;
    • Usmani, Saad Z.;
    • Plesner, Torben;
    • Lonial, Sagar;
    • Nijhof, Inger;
    • Lokhorst, Henk M.;
    • Mutis, Tuna;
    • Donk, Niels W.C.J.;
    • Sasser, Amy Kate;
    • Casneuf, Tineke
    Publication type:
    Article
    48
    49
    50